What is the share price of Themis Medicare Ltd (THEMISMED) today?
The share price of THEMISMED as on 19th June 2025 is ₹130.44. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Themis Medicare Ltd (THEMISMED) share?
The past returns of Themis Medicare Ltd (THEMISMED) share are- Past 1 week: -7.23%
- Past 1 month: -12.45%
- Past 3 months: -10.75%
- Past 6 months: -50.59%
- Past 1 year: -38.32%
- Past 3 years: 78.39%
- Past 5 years: 319.14%
What are the peers or stocks similar to Themis Medicare Ltd (THEMISMED)?
The peers or stocks similar to Themis Medicare Ltd (THEMISMED) include:What is the market cap of Themis Medicare Ltd (THEMISMED) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Themis Medicare Ltd (THEMISMED) is ₹1231.77 Cr as of 19th June 2025.What is the 52 week high and low of Themis Medicare Ltd (THEMISMED) share?
The 52-week high of Themis Medicare Ltd (THEMISMED) is ₹317 and the 52-week low is ₹115.What is the PE and PB ratio of Themis Medicare Ltd (THEMISMED) stock?
The P/E (price-to-earnings) ratio of Themis Medicare Ltd (THEMISMED) is 41.28. The P/B (price-to-book) ratio is 3.26.Which sector does Themis Medicare Ltd (THEMISMED) belong to?
Themis Medicare Ltd (THEMISMED) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Themis Medicare Ltd (THEMISMED) shares?
You can directly buy Themis Medicare Ltd (THEMISMED) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Themis Medicare Ltd
THEMISMED Share Price
How to use scorecard? Learn more
THEMISMED Performance & Key Metrics
THEMISMED Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
41.29 | 3.26 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
35.65 | 6.55 | 0.84% |
THEMISMED Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
THEMISMED Company Profile
Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.
THEMISMED Forecast
THEMISMED Forecasts
THEMISMED
THEMISMED
Income
Balance Sheet
Cash Flow
THEMISMED Income Statement
THEMISMED Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 220.73 | 215.11 | 188.69 | 213.96 | 243.77 | 412.49 | 379.44 | 405.32 | 416.11 | 420.58 | ||||||||||
Raw Materials | 74.53 | 73.15 | 68.81 | 66.67 | 79.48 | 145.08 | 126.16 | 138.28 | 356.46 | 360.94 | ||||||||||
Power & Fuel Cost | 9.77 | 8.41 | 9.70 | 11.49 | 11.32 | 12.18 | 11.83 | 13.46 | ||||||||||||
Employee Cost | 40.00 | 44.65 | 45.69 | 44.28 | 39.99 | 51.97 | 66.15 | 82.41 | ||||||||||||
Selling & Administrative Expenses | 35.57 | 37.20 | 35.28 | 26.34 | 26.96 | 44.73 | 51.04 | 59.01 | ||||||||||||
Operating & Other expenses | 23.98 | 21.08 | 22.00 | 17.15 | 23.43 | 45.02 | 31.70 | 37.09 | ||||||||||||
EBITDA | 36.88 | 30.62 | 7.21 | 48.03 | 62.59 | 113.51 | 92.56 | 75.07 | 59.65 | 59.64 | ||||||||||
Depreciation/Amortization | 7.47 | 7.42 | 7.99 | 8.27 | 8.55 | 9.48 | 10.49 | 12.25 | 9.93 | 9.93 | ||||||||||
PBIT | 29.41 | 23.20 | -0.78 | 39.76 | 54.04 | 104.03 | 82.07 | 62.82 | 49.72 | 49.71 | ||||||||||
Interest & Other Items | 11.84 | 11.87 | 11.82 | 12.88 | 12.71 | 8.77 | 9.56 | 9.38 | 10.04 | 10.04 | ||||||||||
PBT | 17.57 | 11.33 | -12.60 | 26.88 | 41.33 | 95.26 | 72.51 | 53.44 | 39.68 | 39.67 | ||||||||||
Taxes & Other Items | 1.60 | 0.04 | -1.86 | 2.09 | 5.63 | 22.38 | 15.61 | 9.92 | 9.84 | 9.84 | ||||||||||
Net Income | 15.97 | 11.29 | -10.74 | 24.79 | 35.70 | 72.88 | 56.90 | 43.52 | 29.84 | 29.83 | ||||||||||
EPS | 1.82 | 1.24 | -1.17 | 2.70 | 3.89 | 7.93 | 6.18 | 4.73 | 3.24 | 3.24 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.18 | 0.43 | 0.50 | 0.50 | 0.50 | 0.00 | 0.50 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.06 | 0.08 | 0.11 | 0.00 | 0.15 |
THEMISMED Company Updates
Investor Presentation
THEMISMED Stock Peers
THEMISMED Past Performance & Peer Comparison
THEMISMED Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Themis Medicare Ltd | 41.28 | 3.26 | — |
Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
Cipla Ltd | 22.95 | 4.51 | 1.07% |
Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
THEMISMED Stock Price Comparison
Compare THEMISMED with any stock or ETFTHEMISMED Holdings
THEMISMED Shareholdings
THEMISMED Promoter Holdings Trend
THEMISMED Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
THEMISMED Institutional Holdings Trend
THEMISMED Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
THEMISMED Shareholding Pattern
THEMISMED Shareholding Pattern
THEMISMED Shareholding History
THEMISMED Shareholding History
Mutual Funds Invested in THEMISMED
Mutual Funds Invested in THEMISMED
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Themis Medicare Ltd
Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 103/109 (-9) |
Compare 3-month MF holding change on Screener
smallcases containing THEMISMED stock
smallcases containing THEMISMED stock
Looks like this stock is not in any smallcase yet.
THEMISMED Events
THEMISMED Events
THEMISMED Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
THEMISMED Dividend Trend
No dividend trend available
THEMISMED Upcoming Dividends
THEMISMED Upcoming Dividends
No upcoming dividends are available
THEMISMED Past Dividends
THEMISMED Past Dividends
Cash Dividend
Ex DateEx DateJul 12, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Jul 12, 2024
Cash Dividend
Ex DateEx DateSep 1, 2023
Dividend/Share
₹5.00
Ex DateEx Date
Sep 1, 2023
Cash Dividend
Ex DateEx DateSep 8, 2022
Dividend/Share
₹5.00
Ex DateEx Date
Sep 8, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹4.30
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Dividend/Share
₹1.75
Ex DateEx Date
Sep 17, 2020
THEMISMED Stock News & Opinions
THEMISMED Stock News & Opinions
Themis Medicare announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net loss of Themis Medicare reported to Rs 9.66 crore in the quarter ended March 2025 as against net profit of Rs 6.64 crore during the previous quarter ended March 2024. Sales declined 26.70% to Rs 71.70 crore in the quarter ended March 2025 as against Rs 97.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 31.46% to Rs 29.83 crore in the year ended March 2025 as against Rs 43.52 crore during the previous year ended March 2024. Sales rose 6.22% to Rs 405.51 crore in the year ended March 2025 as against Rs 381.76 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales71.7097.82 -27 405.51381.76 6 OPM %-10.739.51 -12.1013.49 - PBDT-8.6011.80 PL 49.6065.69 -24 PBT-11.138.75 PL 39.6753.44 -26 NP-9.666.64 PL 29.8343.52 -31 Powered by Capital Market - Live
Themis Medicare will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
Net profit of Themis Medicare declined 92.94% to Rs 0.52 crore in the quarter ended December 2024 as against Rs 7.37 crore during the previous quarter ended December 2023. Sales rose 13.70% to Rs 93.81 crore in the quarter ended December 2024 as against Rs 82.51 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.8182.51 14 OPM %6.369.77 - PBDT4.2011.31 -63 PBT1.668.22 -80 NP0.527.37 -93 Powered by Capital Market - Live
Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
Net profit of Themis Medicare rose 26.24% to Rs 14.29 crore in the quarter ended September 2024 as against Rs 11.32 crore during the previous quarter ended September 2023. Sales rose 11.67% to Rs 117.01 crore in the quarter ended September 2024 as against Rs 104.78 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales117.01104.78 12 OPM %14.6411.84 - PBDT20.2517.03 19 PBT17.8013.96 28 NP14.2911.32 26 Powered by Capital Market - Live
Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live
Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter

Net profit of Themis Medicare rose 35.68% to Rs 24.68 crore in the quarter ended June 2024 as against Rs 18.19 crore during the previous quarter ended June 2023. Sales rose 27.25% to Rs 122.99 crore in the quarter ended June 2024 as against Rs 96.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales122.9996.65 27 OPM %23.7322.49 - PBDT33.7525.54 32 PBT31.3522.52 39 NP24.6818.19 36 Powered by Capital Market - Live
Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.52%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0.09% to 0.11%